前收市價 | 150.31 |
開市 | 154.41 |
買盤 | 152.29 x 200 |
賣出價 | 152.55 x 100 |
今日波幅 | 151.91 - 155.41 |
52 週波幅 | 141.98 - 218.88 |
成交量 | |
平均成交量 | 834,624 |
市值 | 19.262B |
Beta 值 (5 年,每月) | 0.40 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -3.52 |
業績公佈日 | 2024年8月01日 - 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 222.45 |
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.